Home >> Report Store >> Healthcare >> Transplantation Market Size, Share & Industry Report, 2025 >

Transplantation Market, By Product (Immunosuppressive Drugs, Preservation Solutions and Tissue Products), By Type, By End Use and Geography (North America, Europe, Asia Pacific, and Rest of the World) – Analysis, Share, Trends, Size, & Forecast from 2014 – 2025

175 Pages | Published Date : March 2019 | Report Code: AV240 | Report Format: PDF

REPORT HIGHLIGHT

The transplantation market was valued at USD 24.93 billion by 2017, growing with 8.8% CAGR during the forecast period, 2018-2025

Market Dynamics

Organ transplantation is an in-demand field of medical science. It encompasses replacing the non-functional organs of patients with a fully functional element from a matched donor. This procedure is most common for kidney, liver, heart, eyes among others. The U.S. Government Information on Organ Donation and Transplantation stated that as of January 2019, over 113,000+ number of patient’s transplant is in waiting list.  The organization also mentioned that the tissue transplant is increasing at rapid pace with more than 1 million procedure performed every year. Thus the demand of the industry unquestionably on a rise.

While the demand-supply gap between donors and recipients is only rising, the pharmaceutical industry is working effectively on improving procedures that enhance success rates of these procedures. An article in CNBC, 2017 stated that medical experts are using newer tools to combat the problems related to organ transplant. For instance, development of tools like norothermic perfusion, allows the organ to be in a body like environment using scientific procedures, thus enhancing chances of success. New technologies such as tissue products, tissue typing technology and surgical medical instruments have further propelled the growth of this industry significantly. Tissue banks are commonly used to store the tissue that would be used for these procedures. The American Association of Tissue Banks suggested that more than 120 accredited tissue banks are associated with them. This increasing number is also considered to be the key cause of industry growth.  However, shortage of organ donor in the market and the rejection rate when it comes to organ transplantation pull back the market growth to some extent.

Product Takeaway

Based on products, the market is categorized into immunosuppressive drugs, preservation solutions, and tissue products. Tissue transfer procedure is one of the highest revenue generating segment. Followed by which, immunosuppressive drugs show the most promising growth. A study published in the American Journal of Transplantation, 2016 mentioned that immunosuppressant drugs could be the future of transplantation industry as it reducing the rejection risk and eventually increase success rates of transplantation. It is noted that more and more pharmaceutical companies are spending their R&D money on improving the portfolio of this product category, supporting the segment growth. On contrary, preservation solution category is seen to be growing at a rapid pace due to its increased usage in transplantation procedures.

Application Takeaway

Application wise, the two major categories are; tissue and organ transplantation. Of these, tissue method accounted for the significant revenue share owing to the increasing number of corneal transplants across the globe. As per the American Transplant Foundation, more than 40,000 corneal transplant procedure take place every year in the U.S. alone. This is followed by organ transplantation, growing with 8.5% CAGR during the study period. Based on statistics published on the website of Finger Lakes Donor Recovery Network, one new person is added to the organ transplant list every 10 minutes.

End-Use Takeaway

End-user segment is divided into hospitals, transplant centres and others. Hospitals recorded USD 13.21 billion in 2017 and is projected to maintain its dominance over the study period. Hospital facilities are now getting more equipped to carry out complete organ preservation and transplantation processes. Thus, these facilities are considered to be the key place where most transplant-related decisions occur, driving the segment growth to great extent.

Regional Takeaway

North America is one of the leaders of this market due to the effective steps carried out by key players to improve transplant procedures. In addition, new rules and guidelines are being implemented by government that are constantly improving the scope of organ transplantation industry in region. Europe is accounted for the 30% revenue share owing to the increasing number of organ donor. Based on data published in 2017, MINISTERIO DE SANIDAD, Spain was the leader in terms of organ donation.

Key Vendor Takeaway

This industry is fragmented and includes various players include AbbVie Inc.; Zimmer Biomet; Medtronic; Teva Pharmaceuticals; Stryker; 21st Century Medicine; BioLife Solutions, Inc.; Novartis AG; Arthrex, Inc..; and Veloxis Pharmaceuticals. Novartis took over Selexys Pharmaceuticals in the year 2016, it has gone ahead to launch drug called Zortress which prevents organ rejection in adult liver transplantation patients.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year – 2014 & 2016
  • Base Year – 2017
  • Estimated Year – 2018
  • Projected Year – 2025

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY PRODUCT

  • Immunosuppressive Drugs
  • Preservation Solutions
  • Tissue Products

MARKET, BY TYPE

  • Tissue Transplantation
  • Organ Transplantation

MARKET, BY END USE

  • Hospitals
  • Transplant Centers
  • Others

MARKET, BY REGION

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

TABLE OF CONTENT

1. TRANSPLANTATION MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. TRANSPLANTATION KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. TRANSPLANTATION INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Market Attractiveness Analysis
4.3. Regulatory Framework Analysis
5. TRANSPLANTATION MARKET LANDSCAPE
5.1. Market Share Analysis
6. TRANSPLANTATION MARKET – BY PRODUCT
6.1. Overview
6.2. Immunosuppressive drugs
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3. Preservation solutions
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.4. Tissue products
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7. TRANSPLANTATION MARKET – BY TYPE
7.1. Overview
7.2. Tissue Transplantation
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3. Organ Transplantation
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8. TRANSPLANTATION MARKET – BY END USE
8.1. Overview
8.2. Hospitals
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3. Transplant Centers
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4. Others
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9. TRANSPLANTATION MARKET– BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.2.3. U.S.
9.2.3.1. Overview
9.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.2.4. Canada
9.2.4.1. Overview
9.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3. Europe
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3.3. France
9.3.3.1. Overview
9.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3.4. Germany
9.3.4.1. Overview
9.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3.5. Rest of Europe
9.3.5.1. Overview
9.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4.3. China
9.4.3.1. Overview
9.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4.4. India
9.4.4.1. Overview
9.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4.5. Rest of APAC
9.4.5.1. Overview
9.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.5. Rest of the World
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.5.3. Latin America
9.5.3.1. Overview
9.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.5.4. Middle East and Africa
9.5.4.1. Overview
9.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
10. KEY VENDOR ANALYSIS
10.1. AbbVie Inc.
10.1.1. Company Overview
10.1.2. SWOT Analysis
10.1.3. Key Developments
10.2. Zimmer Biomet
10.2.1. Company Overview
10.2.2. SWOT Analysis
10.2.3. Key Developments
10.3. Medtronic plc
10.3.1. Company Overview
10.3.2. SWOT Analysis
10.3.3. Key Developments
10.4. Teva Pharmaceuticals
10.4.1. Company Overview
10.4.2. SWOT Analysis
10.4.3. Key Developments
10.5. Stryker Corporation
10.5.1. Company Overview
10.5.2. SWOT Analysis
10.5.3. Key Developments
10.6. 21st Century Medicine
10.6.1. Company Overview
10.6.2. SWOT Analysis
10.6.3. Key Developments
10.7. BioLife Solutions, Inc.
10.7.1. Company Overview
10.7.2. SWOT Analysis
10.7.3. Key Developments
10.8. Novartis AG
10.8.1. Company Overview
10.8.2. SWOT Analysis
10.8.3. Key Developments
10.9. Arthrex, Inc.
10.9.1. Company Overview
10.9.2. SWOT Analysis
10.9.3. Key Developments
10.10. Veloxis Pharmaceuticals
10.10.1. Company Overview
10.10.2. SWOT Analysis
10.10.3. Key Developments
11. 360 DEGREE ANALYSTVIEW
12. APPENDIX
12.1. Research Methodology
12.2. Abbreviations
12.3. Disclaimer
12.4. Contact Us

List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Transplantation Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
Table 10 Transplantation Market, by Product, 2014 – 2025 (USD Billion)
Table 11 Transplantation Market, by Type, 2014 – 2025 (USD Billion)
Table 12 Transplantation Market, by End Use, 2014 – 2025 (USD Billion)
Table 13 Transplantation Market, by Geography, 2014 – 2025 (USD Billion)
Table 14 North America Transplantation Market, 2014 – 2025 (USD Billion)
Table 15 U.S. Transplantation Market, 2014 – 2025 (USD Billion)
Table 16 Canada Transplantation Market, 2014 – 2025 (USD Billion)
Table 17 Europe Transplantation Market, 2014 – 2025 (USD Billion)
Table 18 France Transplantation Market, 2014 – 2025 (USD Billion)
Table 19 Germany Transplantation Market, 2014 – 2025 (USD Billion)
Table 20 Asia Pacific Transplantation Market, 2014 – 2025 (USD Billion)
Table 21 China Transplantation Market, 2014 – 2025 (USD Billion)
Table 22 India Transplantation Market, 2014 – 2025 (USD Billion)
Table 23 Latin America Transplantation Market, 2014 – 2025 (USD Billion)
Table 24 MEA Transplantation Market, 2014 – 2025 (USD Billion)

List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Transplantation Market, by Product, 2014 – 2025 (USD Billion)
Figure 6 Transplantation Market, by Type, 2014 – 2025 (USD Billion)
Figure 7 Transplantation Market, by End Use, 2014 – 2025 (USD Billion)
Figure 8 Transplantation Market, by Geography, 2014 – 2025 (USD Billion)

SCOPE AND OBJECTIVES
The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the market. The scope of this report covers the market by its major segments.

KEY BENEFITS OF THE REPORT
– The report presents macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
– Thorough analysis of relevant statistical data to estimate the market paradigms
– Exceptional understanding of region and country specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts, and growth specific to the countries.
– Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

RESEARCH METHODOLOGY

Research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study includes extensive use of secondary sources, paid databases (such as Bloomberg, Dun & Bradstreet, and BusinessWeek) and directories, to identify and collect information, useful to understand technical, commercial and market-oriented aspects. Market data and information are also collected (but not limited to) from the secondary sources such as:

  • Official company’s website, financial and annual reporting
  • Government statistical data
  • Online publishing articles
  • Industry player’s investor presentations
  • Economic news articles
  • National and international trade associations
  • The financial, business, and mainstream press
  • Industry study groups and semiofficial sources
  • Informative channels related to the market topics

* Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary            information often conflicting across multiple sources is a key aspect of the added value we provide

In order to verify and validate secondary market data, we engage with the Key Opinion Leaders (KoL’s), operating in the respective markets, through phone calls, emails, and web-based survey responses. This platform help us validate our data in terms of accuracy and gain insight into the current market and future expectations. Furthermore, the obtained information guide us to understand several facets of the market with respect to manufacturers and buyers’ perspectives.

In addition, to assign weights to all the relevant market dynamics and parameters and quantify their market impact for generating projected market growth rate, we used advanced machine learning algorithms in order to collate essential market data. The machine learning method utilizes algorithms such as regression, correlation, and decision tree, among others, to derive the desired output. This tool help us in deriving highly detailed forecasts, profound knowledge of product demand, and others.

These collected data points are carefully filtered, analyzed, compared, and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level, and global level.

Market Forecast :

Market forecast is primarily based on the year-on-year (YOY) growth rate. Data projection and future performance of each segment is analyzed based on the key aspects extracted from primary and secondary research results. Thus, data projection exhibits the assumption on how the market performs under microeconomic and macroeconomic parameters. Our market forecasting technique represents strategic conclusions which can play a crucial role for our client’s in making strategic marketing plans.

For forecasting, the following parameters were considered:

  • Market drivers and restraints along with their current and expected impacts
  • Technological scenario and expected developments
  • Trends in the consumer behaviors
  • End-user industry trends

We have assigned weights to above-mentioned parameters and quantified their market impacts using the weighted average analysis, to derive an expected market growth rate.

Market Analysis

Another integral part of our research study is that market data is accompanied by clear written analysis. We include detailed information on market segments in terms of market drivers, market restraints, and market opportunities. These offer insights on different channel dynamics, brand preference, incidence/prevalence data, consumption trend, and technology up-gradations.

We also include supporting data from relevant awareness campaigns, new introductions, regulatory norms, government initiatives, and an industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.

Why AnalystView?

Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Y

Tailor-Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

T

Data Accuracy and Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This